Type 1 diabetes advocacy group, T1 International, organized the rally, where people called on pharmaceutical companies like Eli Lilly to make insulin and other life-saving drugs more affordable.
One in four people with diabetes rations insulin because they can’t afford it, according to a study published in JAMA conducted by researchers from New Haven, Conn.-based Yale University
Read the full report here.
More articles on pharmacy:
California biotech files for bankruptcy
Ohio’s Medicaid director may give results of drug pricing report in front of oversight committee
